- Patent Title: Imidazopiperazine inhibitors of transcription activating proteins
-
Application No.: US16370404Application Date: 2019-03-29
-
Publication No.: US11058688B2Publication Date: 2021-07-13
- Inventor: Kang Le , Michael J. Soth , Philip Jones , Jason Bryant Cross , Christopher L. Carroll , Timothy Joseph McAfoos , Pijus Kumar Mandal
- Applicant: Board of Regents, The University of Texas System
- Applicant Address: US TX Austin
- Assignee: Board of Regents, The University of Texas System
- Current Assignee: Board of Regents, The University of Texas System
- Current Assignee Address: US TX Austin
- Agent Dennis A. Bennett; Lauren L. Stevens; John Desper
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/4985 ; A61K31/5377 ; C07D495/04 ; C07D471/04
Abstract:
The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of transcription activating proteins such as CBP and P300 for the treatment or prevention of diseases such as proliferative diseases, inflammatory disorders, autoimmune diseases, and fibrotic diseases.
Public/Granted literature
- US20190298729A1 IMIDAZOPIPERAZINE INHIBITORS OF TRANSCRIPTION ACTIVATING PROTEINS Public/Granted day:2019-10-03
Information query
